$1.47
-0.68%
2026-09-04 11:00:50 EDT-$0.01
보건의료
생명공학
NASDAQ
활발히 거래 중
Aldeyra Therapeutics, Inc.는 생명공학 기업으로서 면역 매개 질환을 치료하도록 설계된 치료제를 발견하고 개발합니다. 주요 파이프라인 후보 물질은 반응성 알데하이드 종(RASP) 조절제인 reproxalap이며, ...
Aldeyra Therapeutics, Inc.는 생명공학 기업으로서 면역 매개 질환을 치료하도록 설계된 치료제를 발견하고 개발합니다. 주요 파이프라인 후보 물질은 반응성 알데하이드 종(RASP) 조절제인 reproxalap이며, ...
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Miller-Rich Nancy | director | Stock Option (Right to Buy) | A | 70,000 | $1.72 |
| Jun 9, 2026 | Miller-Rich Nancy | director | Stock Option (Right to Buy) | A | 3,318 | $1.72 |
| Jun 9, 2026 | DOUGLAS RICHARD | director | Stock Option (Right to Buy) | A | 70,000 | $1.72 |
| Jun 9, 2026 | DOUGLAS RICHARD | director | Stock Option (Right to Buy) | A | 19,909 | $1.72 |
| Jun 9, 2026 | DOUGLAS RICHARD | director | Stock Option (Right to Buy) | A | 2,323 | $1.72 |
매수/매도 주식 수와 종가 추세(공통 일간 가격 소스)
X축: 주식 수, 총 주식 수 내림차순
X축: 건수, A+D 건수 내림차순
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 | 금액 |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Miller-Rich Nancy | director | Stock Option (Right to Buy) | A | 70,000 | $1.72 | $120,400.00 |
| Jun 9, 2026 | Miller-Rich Nancy | director | Stock Option (Right to Buy) | A | 3,318 | $1.72 | $5,706.96 |
| Jun 9, 2026 | DOUGLAS RICHARD | director | Stock Option (Right to Buy) | A | 70,000 | $1.72 | $120,400.00 |
| Jun 9, 2026 | DOUGLAS RICHARD | director | Stock Option (Right to Buy) | A | 19,909 | $1.72 | $34,243.48 |
| Jun 9, 2026 | DOUGLAS RICHARD | director | Stock Option (Right to Buy) | A | 2,323 | $1.72 | $3,995.56 |
| Jun 9, 2026 | Phillips Gary M. | director | Stock Option (Right to Buy) | A | 70,000 | $1.72 | $120,400.00 |
| Jun 9, 2026 | Phillips Gary M. | director | Stock Option (Right to Buy) | A | 6,636 | $1.72 | $11,413.92 |
| Jun 9, 2026 | Phillips Gary M. | director | Stock Option (Right to Buy) | A | 4,977 | $1.72 | $8,560.44 |
| Jun 9, 2026 | Clark William D | director | Stock Option (Right to Buy) | A | 70,000 | $1.72 | $120,400.00 |
| Jun 9, 2026 | Clark William D | director | Stock Option (Right to Buy) | A | 2,323 | $1.72 | $3,995.56 |